Boxlight Q2 revenue down ~20% as adjusted EBITDA improves; $39M term loan due Dec 2025

Snapshot - Boxlight Corporation (NASDAQ: BOXL)

Quarterly update from the company's 10‑Q (period ended June 30, 2025). The business is seeing reduced revenue but some operating improvements; liquidity and debt maturities remain the biggest near‑term risks.

Key facts & figures (from the 10‑Q)
* Revenues, net - three months ended June 30, 2025: $30,852 (in thousands) vs $38,514 in Q2 2024 (‑19.9%).
* Revenues, net - six months ended June 30, 2025: $53,275 (in thousands) vs $75,608 in prior year (‑29.5%).
* Gross profit - Q2 2025: $10,790 (in thousands); gross margin Q2 2025: 35.0% (Q2 2024: 37.7%).
* Operating loss - Q2 2025: $(3,912) (in thousands) vs operating income $1,222 in Q2 2024.
* Net loss - Q2 2025: $(4,719) (in thousands); net loss attributable to common stockholders Q2 2025: $(5,036) (in thousands).
* Net loss - six months 2025: $(7,962) (in thousands) vs $(8,567) in six months 2024.
* Net loss per share, basic & diluted - Q2 2025: $(1.53) vs $(0.92) Q2 2024; weighted average shares Q2 2025: 3,296 vs 1,958.
* Cash & cash equivalents at June 30, 2025: $7,608 (in thousands).
* Accounts receivable, net: $21,439 (in thousands). Inventories, net: $28,190 (in thousands) (down from $43,265 at 12/31/24).
* Total assets: $99,201 (in thousands); total liabilities: $91,321 (in thousands); stockholders' deficit: $(20,629) (in thousands).
* Short‑term debt (current portion): $39,034 (in thousands); Term Loan outstanding $39.0M (matures December 31, 2025).
* Mezzanine equity - Series B & C preferred: $28,509 (in thousands) (redeemable/convertible features create additional obligations).
* Warrants & derivatives: common warrants fair value (Level 3) $1,711 (in thousands); derivative liabilities $52 (in thousands); LTIP Level 3 liability $71 (in thousands).
* Debt & covenant actions: multiple covenant breaches waived via amendments and forbearances (Eighth & Ninth Amendments / Forbearance dated Aug 13, 2025); bridge loans and covenant concessions in place; bridge loan due/forgiven timing noted in filings.
* Private placement Feb 2025: gross proceeds approx. $2.8 million; issued warrants (2025 Common Warrants) to purchase up to 1,323,000 shares.

Positive aspects on the income statement / operations
* Adjusted EBITDA and EBITDA were positive in Q2 2025 (EBITDA $717; Adjusted EBITDA $1,273 - all amounts in thousands), showing operating cash‑profit trends when non‑cash items are removed.
* Gross margin remains respectable (~35%), indicating product mix and pricing still support margin even with lower volumes.
* Other expense, net improved year‑over‑year in Q2 2025 (lower negative impact than prior year), helped reduce total other charges.
* Cash burn from operations improved: net cash used in operating activities for six months 2025 was $(3,100) (in thousands) vs $(7,309) prior year - progress toward better working capital management.

Negative aspects on the income statement / red flags
* Significant revenue decline: Q2 revenue down ~20% YoY and six‑month revenue down ~30% YoY - demand weakness for interactive flat panels is the main driver.
* Operating loss in Q2 (‑$3.9M) after a prior‑year operating profit in that quarter - operating leverage is under pressure.
* Net loss remains substantial: $(7.96M) YTD; EPS hit by higher share count (weighted avg shares jumped to 3,296) causing dilution.
* Interest expense is meaningful: Q2 interest expense $2,571 (in thousands) and term debt of ~$39M matures Dec 31, 2025 - puts pressure on cash flow.
* Stockholders' deficit and mezzanine preferred redemption/convertibility obligations (~$28.5M) create balance sheet risk.
* Fair‑value swings on warrants and derivatives (common warrants valued at $1.711M) introduce volatility to reported results and potential cash conversion differences.
* Inventory purchase commitments remain material: open inventory purchase orders $27.8M (in thousands), representing a cash commitment while demand is down.

What's happening inside the company - synopsis
* Management is cutting costs (employee expenses down YTD, lower R&D and G&A initiatives noted), working to stabilize margins and improve operating cash flow.
* The company raised ~ $2.8M in February 2025 private placement and obtained multiple lender amendments/waivers (bridge loans) to avoid default; forbearance and ninth amendment granted Aug 13, 2025 but key covenants and debt maturities remain a major near‑term issue.
* Governance & Nasdaq compliance: reverse stock split (1‑for‑5) in Feb 2025, shareholder approval Aug 8, 2025 to increase authorized Class A shares to 25M to allow share settlement of warrants; Nasdaq provided notices and accepted a compliance plan (deadline Oct 6, 2025) - there are additional director independence / audit committee matters to cure by Nov 19, 2025.
* Management focus: refinancing the Term Loan, meeting lender milestones (recapitalization requirement not met on original timetable), and reducing working capital strain. The 10‑Q explicitly discloses substantial doubt about going concern absent refinancing or covenant relief.

Near‑term catalysts / items to watch
* Success or failure of refinancing/repayment prior to Dec 31, 2025 Term Loan maturity - this is the single largest go/no‑go risk.
* Lender waivers/forbearance developments and whether additional fees or stricter covenants are imposed.
* Trending revenue and order intake (seasonality into school buying season) and whether sequential improvement continues (Q2 was up vs prior quarter sequentially per MD&A).
* Warrant exercise activity and dilution if exercised, and potential cash inflows vs additional share overhang.
* Inventory order consumption vs backlog: open purchase orders ~$27.8M - watch how much converts to revenue given soft demand.

Bottom line: Boxlight (NASDAQ: BOXL) is operating with positive signs in adjusted EBITDA and margin stabilization but is constrained by falling revenue, a weak balance sheet (stockholders' deficit), substantial debt that matures within a year, and recurring covenant breaches that require lender accommodations. The company's survival over the next 12 months hinges on refinancing / covenant relief and improved cash generation.